Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/11/15 → 12/11/18 |
Funding
- Covance Inc. (Prot #NEOD001-CL002 // Prot #NEOD001-CL002)
- Prothena Therapeutics Limited (Prot #NEOD001-CL002 // Prot #NEOD001-CL002)
Prot #NEOD001-CL002: A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, 2-Arm, Efficacy and Safety Study of NEOD001 Plus Standard of Care vs. Placebo Plus Standard of Care in Subjects with Light Chain (AL) Amyloidosis
- Singhal, Seema (PD/PI)
Project: Research project